Connect with Fogarty
NIH researchers examine how artemisinin resistant malaria is emerging due to prevalence of poor-quality and fake malaria drugs
Malaria is a mosquito-borne disease causing fever, chills and flu-like illness that can be fatal. Despite an increased focus on malaria, it still claims hundreds of thousands of lives each year, most of them children in Africa. Poor quality antimalarial drugs, which lead to drug resistance and inadequate treatment, are also a growing concern, posing an urgent threat to vulnerable populations.
Fogarty has supported a wide range of efforts to combat malaria, including the Multilateral Initiative on Malaria, an international effort to identify and address malaria research priorities. Ecology and Evolution of Infectious Diseases, a joint NIH - National Science Foundation (NSF) initiative, funds malaria-related projects in Kenya, Papua New Guinea, Belize and more. Through the Global Infectious Disease program, Fogarty has supported research training efforts that advance scientific discoveries, while developing local malaria research capacity in places where it's needed most.
Fogarty's epidemiology division studies malaria transmission patterns, drug resistance and other related topics, modeling malaria's prevalence and impact.
NICHD/NIH news, July 11, 2018